COVID-19 Infection: Impact on Hair

October 2021 in “ Indian Journal of Plastic Surgery ”

Sandeep Sattur, Indu Sandeep Sattur

hair fall COVID-19 SARS-CoV-2 hair follicle infection hair loss coronavirus

TLDR COVID-19 may cause increased and quicker hair loss compared to other infections.

The document "COVID-19 Infection: Impact on Hair" discusses the observation of increased hair fall in patients following COVID-19 infection. The authors, who specialize in hair restoration and hair loss management, noted that the period between the infection and the onset of hair fall was shorter in the case of COVID-19 compared to other infections. The review explores the different pathways responsible for hair fall and investigates whether the SARS-CoV-2 virus has a direct impact on the hair follicle, leading to hair loss. The authors aim to understand if the hair fall pattern after COVID-19 infection differs from conventional hair fall seen after other infections.

View this study on thieme-connect.de →

Discuss this study in the Community →

Research cited in this study

16 / 16 results

research Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium

32 citations, July 2021 in “Journal of The American Academy of Dermatology”

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

research A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection

14 citations, April 2021 in “Clinical, Cosmetic and Investigational Dermatology”

COVID-19 may trigger sudden temporary hair loss.

research Telogen Effluvium Associated with COVID-19 Infection

44 citations, January 2021 in “Dermatologic Therapy”

COVID-19 may cause hair loss due to infection stress or treatments.

research Telogen Effluvium After SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms

28 citations, January 2021 in “Skin appendage disorders”

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

research What Can Hair Tell Us About COVID-19?

27 citations, December 2020 in “Experimental Dermatology”

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

research Telogen Effluvium: A Sequela of COVID-19

58 citations, November 2020 in “International Journal of Dermatology”

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

research Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience

35 citations, November 2020 in “Dermatologic Therapy”

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

research Telogen Effluvium: A Comprehensive Review

56 citations, August 2019 in “Clinical, Cosmetic and Investigational Dermatology”

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

research Dengue Virus Infects Primary Human Hair Follicle Dermal Papilla Cells

14 citations, August 2018 in “Frontiers in Cellular and Infection Microbiology”

Dengue virus can infect human hair follicle cells and may cause hair loss.

research Hair Pull Test: Evidence-Based Update and Revision of Guidelines

36 citations, December 2016 in “Journal of The American Academy of Dermatology”

The normal range for the hair pull test is 2 hairs or fewer, and washing or brushing hair before the test does not affect the results.

research Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature

31 citations, January 2016 in “Drugs - Real World Outcomes”

Some new oral anticoagulants may also cause hair loss and might not be better than traditional ones for preventing hair loss.

research Telogen Effluvium: A Review

70 citations, January 2015 in “Journal of Clinical and Diagnostic Research”

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

research Anagen Effluvium: A Review of Rapid Hair Loss During Growth Phase and Loose Anagen Hair Syndrome

61 citations, January 2013 in “Indian Journal of Dermatology, Venereology and Leprology”

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

research Trichoscopy in Alopecias: Diagnosis Simplified

96 citations, January 2013 in “International Journal of Trichology”

Trichoscopy is a useful, non-invasive way to diagnose different types of hair loss.

research Telogen Effluvium: A Review of Acute and Chronic Forms

67 citations, January 2013 in “Indian Journal of Dermatology, Venereology and Leprology”

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

research Burden of Hair Loss: Stress and the Underestimated Psychosocial Impact of Telogen Effluvium and Androgenetic Alopecia

162 citations, August 2004 in “Journal of Investigative Dermatology”

Hair loss causes stress and affects mental health; treatment and support needed.

Related Research

3 / 3 results

research Protection Against Chemotherapy-Induced Alopecia: Targeting ATP-Binding Cassette Transporters in the Hair Follicle

24 citations, November 2013 in “Trends in pharmacological sciences”

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

research Pathobiology of Chemotherapy-Induced Hair Loss

218 citations, January 2013 in “The Lancet Oncology”

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

research Towards a Molecular Understanding of Hair Loss and Its Treatment

236 citations, July 2001 in “Trends in Molecular Medicine”

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.